Astrotech Corporation is a multifaceted organization that focuses on advanced technology and scientific innovation in various fields, primarily through its subsidiaries, 1st Detect, Astrogenetix, and Astral Images. The company specializes in developing products and services that cater to analytical chemistry, biotechnology, and image correction technologies, leveraging its unique capabilities and partnerships.
1. 1st Detect
1st Detect is a pioneer in the development, manufacture, and commercialization of miniaturized transportable mass spectrometers and related equipment. Mass spectrometry is a pivotal analytical technique used for measuring the mass and relative abundance of ions in a sample, generating a “mass spectrum” that serves as a unique identifier for various substances. By employing advanced technology initially developed for NASAs International Space Station (ISS), 1st Detect has made significant strides in creating instruments that are notably smaller, lighter, faster, and less expensive than traditional mass spectrometers while also offering superior sensitivity and accuracy compared to other chemical detection methods.
Key Products
- MMS-1000™: This small, low-power mass spectrometer was initially designed for the laboratory market but has extensive applications in various fields. About the size of a shoebox and consuming less power than a typical light bulb, the MMS-1000™ enables high-quality chemical analysis in diverse environments. It is particularly suitable for locations where traditional mass spectrometers have typically not been utilized, such as airports for explosives detection, factory floors, and field operations in military settings.
- OEM-1000: This component is engineered to be integrated into customers existing technologies. Recent integrations have included the Thermo iMS2, the world’s first thermogravimetric analyzer (TGA) that combines tandem mass spectrometry (MS/MS) capabilities, developed in collaboration with RIGAKU of Tokyo, Japan. Additionally, the OEM-1000 has been selected for integration into the Next Generation Chemical Detector (NGCD) being developed by Battelle, which aims to enhance military chemical detection capabilities.
Astrogenetix
Astrogenetix is a biotechnology firm focused on commercializing innovative vaccine targets identified in microgravity environments. The companys efforts are part of a collaboration with NASA and the University of Marylands Center for Vaccine Development, a notable institution in vaccinology. The primary objective is to file an Investigational New Drug (IND) application for a vaccine targeting Salmonella. NASA supports this research financially, minimizing the investment required from Astrogenetix.
Astrogenetix has also established a Space Act Agreement with NASA, which guarantees a minimum of twenty-eight additional space flights aimed at furthering vaccine research after the successful IND application for Salmonella is filed. This strategic partnership with NASA enhances Astrogenetixs research capabilities and positions it as a forefront player in the biotechnology sector.
Astral Images
Astral Images was established to leverage government-funded satellite image correction technologies, focusing on the digital restoration of visual media. The subsidiary acquired specific defect correction technologies from Image Trends, Inc. through bankruptcy proceedings, ensuring it obtained the intellectual property pivotal for advancing its capabilities in this area.
Key Achievements:
- Technology Acquisition: Astral secured innovative film defect correction technology initially developed through collaboration between IBM and Kodak, which provides a foundational base for future enhancements.
- Market Positioning: With the acquired technology and a team of skilled engineers from Image Trends, Astral aims to adapt its capabilities for a range of applications, including digital conversion and restoration of feature films, television series produced on film, archived sporting events, and consumer media. This positioning places Astral at the forefront of the media restoration and image enhancement industry, ready to tackle the challenges of digitizing and preserving historical film content.
Conclusion
Astrotech Corporation showcases a robust portfolio of products and services across its subsidiaries, focusing on cutting-edge technology developed for advanced applications in mass spectrometry, biotechnology, and image correction. Their commitments to research and collaboration, especially with entities like NASA, reflect a dedication to innovation and the promotion of technological advancements that meet the evolving needs of various industries. With its diverse offerings, Astrotech Corporation positions itself as a leader in analytical and life science technologies, while also making significant inroads into media enhancement and preservation.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
64.43 %